ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DSOL Drug Free Solutions Inc (CE)

0.0002
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Drug Free Solutions Inc (CE) USOTC:DSOL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.00 01:00:00

Amended Quarterly Report (10-q/a)

02/10/2013 8:06pm

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q/A

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2012

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission File Number: 333-175525

LIVING BREATH PROJECT, INC.
(formerly known as Dilmax Corp.)
(Exact name of registrant as specified in its charter)

Nevada 99-0365611
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
   
2360 Corporate Circle Suite 400, Henderson, NV 89074
(Address of principal executive offices) (Zip Code)

(855) 426-2647
(Registrant’s telephone number, including area code)

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]     No [   ]

Indicate by check mark whether the Company has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Company was required to submit and post such files).
Yes [X]     No [   ]

Indicate by check mark whether the registrant is a large accelerated filed, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer [   ]            Accelerated filer [   ]            Non-accelerated filer [   ]            Smaller reporting company [X]

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [   ]     No [X]

The number of shares outstanding of the Company's Common Stock as of March 1, 2013 was 28,334,694.

EXPLANATORY NOTE

Explanatory Note: The sole purpose of this Amendment to Living Breath Project, Inc.’s Report on Form 10-Q for the quarter year ended November 30, 2012, filed with the Securities and Exchange Commission on February 28, 2013 (the “Form 10-Q”), is to provide the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language) to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this report provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL. No other changes have been made to the Form 10-K.

Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.


ITEM 6. EXHIBITS

Exhibits:

31.1*

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).

 

 

32.1*

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

   
101.INS* XBRL Instance Document
   
101.SCH* XBRL Taxonomy Schema
   
101.CAL* XBRL Taxonomy Calculation Linkbase
   
101.DEF* XBRL Taxonomy Definition Linkbase
   
101.LAB* XBRL Taxonomy Label Linkbase
   
101.PRE * XBRL Taxonomy Presentation Linkbase

* Furnished herewith.


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LIVING BREATH PROJECT, INC.


Dated: October 2, 2013 By: /s/ Genie O’Malley   
      Name: Genie O’Malley
      Title: President, Chief Executive
        Officer, Chief Financial Officer,
        Secretary and Treasurer
        (Principal Executive Officer and
        Principal Financial Officer)


1 Year Drug Free Solutions (CE) Chart

1 Year Drug Free Solutions (CE) Chart

1 Month Drug Free Solutions (CE) Chart

1 Month Drug Free Solutions (CE) Chart

Your Recent History

Delayed Upgrade Clock